Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 4488213
Author(s) Arnet, Isabelle; Gudka, Sajni; Salter, Sandra; Hersberger, Kurt E.; Clifford, Rhonda
Author(s) at UniBasel Arnet, Isabelle
Hersberger, Kurt
Year 2018
Title Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland
Journal Sexual and Reproductive Healthcare
Volume 16
Pages / Article-Number 138-153
Mesh terms Adolescent; Adult; Attitude of Health Personnel; Australia; Chlamydia; Chlamydia Infections, diagnosis, microbiology; Emotions; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Mass Screening, psychology; Patient Acceptance of Health Care; Pharmaceutical Services; Pharmacists; Pharmacy; Remuneration; Surveys and Questionnaires; Switzerland; Young Adult
Abstract To assess chlamydia knowledge, willingness to undertake pharmacy-based chlamydia testing, and facilitators and barriers to such testing in consumers and community pharmacists, in Australia (AUS) and Switzerland (CH).; Statements of interest were retrieved from literature and assembled into a 12-item online survey (English and German versions). Survey was disseminated through Facebook, pharmacies' publicly available emails and professional websites (March 2015).; Consumers and pharmacists (AUS: n; cons; = 198, n; pharm; = 162; CH: n; cons; = 209, n; pharm; = 223) were predominantly female (>65%). Mean chlamydia knowledge scores (maximum of 8) were higher in Australia in consumers (AUS: 6.8 ± 1.5 vs CH: 4.2 ± 2.4; p < 0.001) and in pharmacists (AUS: 7.1 ± 1.1 vs CH: 6.1 ± 1.4; p < 0.001). High willingness of consumers to seek testing (AUS: 79.3% vs CH: 83.3%, p = 0.3) and of pharmacists to provide testing (AUS: 95.7% vs CH: 80.3%, p < 0.001) was observed. Greatest barrier for consumers was "Embarrassed about asking for a test" (AUS: 47.8% vs CH: 51.2%, p = 0.7) and "No remuneration" for pharmacists (AUS: 40.7% vs CH: 31.8%, p = 0.07).; The majority of consumers and pharmacists support pharmacy-based chlamydia testing. There is now emerging evidence that the policy makers in Australia and Switzerland need to develop pharmacy-based chlamydia testing as core business.
ISSN/ISBN 1877-5764
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.srhc.2018.03.006
PubMed ID
Document type (ISI) Journal Article

MCSS v5.8 PRO. 0.332 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |